Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
Status: | Active, not recruiting |
---|---|
Conditions: | Breast Cancer, Lung Cancer, Lung Cancer, Prostate Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/10/2019 |
Start Date: | August 2014 |
End Date: | February 2023 |
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
This phase I trial studies the side effects and the best dose of stereotactic body radiation
therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate
cancer that has spread to other parts of the body. Stereotactic body radiation therapy
delivers fewer, tightly-focused, high doses of radiation therapy to all known sites of cancer
in the body while minimizing radiation exposure of surrounding normal tissue.
therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate
cancer that has spread to other parts of the body. Stereotactic body radiation therapy
delivers fewer, tightly-focused, high doses of radiation therapy to all known sites of cancer
in the body while minimizing radiation exposure of surrounding normal tissue.
PRIMARY OBJECTIVES:
I. To determine the recommended stereotactic body radiation therapy (SBRT) dose for each of
the metastatic locations being treated given the individual and overlapping fields when
multiple metastases are treated with SBRT in a national clinical trials network setting.
SECONDARY OBJECTIVES:
I. To estimate rates of >= grade 3 Common Terminology Criteria for Adverse Events (CTCAE),
version (v.) 4.0 adverse events other than a dose-limiting toxicity (DLT) which is possibly,
probably, or definitely related to treatment and which occurs within 6 months from the start
of SBRT to multiple metastases.
II. To estimate the rates of long-term adverse events occurring up to 2 years from the end of
SBRT.
III. To explore the most appropriate and clinically relevant technological parameters to
ensure quality and effectiveness throughout radiation therapy processes, including imaging,
simulation, patient immobilization, target and critical structure definition, treatment
planning, image guidance and delivery.
OUTLINE:
Patients undergo 3-5 fractions of image-guided stereotactic body radiation therapy to all
existing metastases over 1-3 weeks with at least 40 hours between treatments for an
individual metastasis.
After completion of study treatment, patients are followed up at 35-45 days and then every 3
months for 2 years.
I. To determine the recommended stereotactic body radiation therapy (SBRT) dose for each of
the metastatic locations being treated given the individual and overlapping fields when
multiple metastases are treated with SBRT in a national clinical trials network setting.
SECONDARY OBJECTIVES:
I. To estimate rates of >= grade 3 Common Terminology Criteria for Adverse Events (CTCAE),
version (v.) 4.0 adverse events other than a dose-limiting toxicity (DLT) which is possibly,
probably, or definitely related to treatment and which occurs within 6 months from the start
of SBRT to multiple metastases.
II. To estimate the rates of long-term adverse events occurring up to 2 years from the end of
SBRT.
III. To explore the most appropriate and clinically relevant technological parameters to
ensure quality and effectiveness throughout radiation therapy processes, including imaging,
simulation, patient immobilization, target and critical structure definition, treatment
planning, image guidance and delivery.
OUTLINE:
Patients undergo 3-5 fractions of image-guided stereotactic body radiation therapy to all
existing metastases over 1-3 weeks with at least 40 hours between treatments for an
individual metastasis.
After completion of study treatment, patients are followed up at 35-45 days and then every 3
months for 2 years.
Inclusion Criteria:
- Metastatic breast cancer (MBC) OR metastatic non-small cell lung cancer (NSCLC) OR
metastatic adenocarcinoma of the prostate; the sites of allowed metastases are:
peripheral lung, central lung, mediastinal/cervical lymph node, liver,
spinal/paraspinal, osseous, and abdominal-pelvic
- NOTE: after the required number of evaluable patients have been accrued for a
given dose level, the accrual for that metastatic location will be temporarily
suspended while the safety of that dose level is assessed; a patient can only be
entered onto the trial if all of their metastatic locations are open to accrual
(e.g. if central lung is temporarily suspended for safety assessment and the
patient has a central lung metastases, regardless of other metastases, they
cannot enroll until the safety of dose to central lung is determined)
- Primary tumor site without progression at registration
- All metastases not resected must be amenable to SBRT
- The patient must meet ONE of the three following criteria:
- 3-4 radiographically distinct metastases of any distribution in the allowed
anatomical sites OR
- 2 radiographically distinct metastases that must be anatomically close (i.e.,
with less than or equal to 5 cm of normal tissue between them) OR
- 3 or 4 distinct metastasis, 2 or 3 to be treated with SBRT and the other (s)
having been surgically removed
- Evaluation by a radiation oncologist within 45 days prior to study registration
- Evaluation by a medical oncologist within 45 days prior to study registration
- The following imaging workup to document metastases within 45 days prior to study
registration:
- Computed tomography (CT) scans of the chest, abdomen and pelvis with radionuclide
bone scan OR whole body positron emission tomography (PET)/CT
- History/physical examination within 45 days prior to study registration
- Zubrod performance status =< 2 within 45 days prior to study registration
- Age >= 18 years
- Absolute neutrophil count (ANC) >= 500 cells/mm^3
- Platelets >= 50,000 /mm^3
- Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve
hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
- If liver metastases present, aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) must be < 3 x upper limit of normal (ULN)
- Patient must provide study specific informed consent prior to study entry
- For females of child-bearing potential, negative serum/urine pregnancy test within 14
days prior to study registration
Exclusion Criteria:
- Progression of primary tumor site (breast, prostate, or lung) at time of registration
- Metastases with indistinct borders making targeting not feasible
- Known brain metastases
- Prior palliative radiotherapy to metastases
- Metastases located within 3 cm of the previously irradiated structures:
- Spinal cord previously irradiated to > 40 Gy (delivered in =< 3 Gy/fraction)
- Brachial plexus previously irradiated to > 50 Gy (delivered in =< 3 Gy/fraction)
- Small intestine, large intestine, or stomach previously irradiated to > 45 Gy
(delivered in =< 3 Gy/fraction)
- Brain stem previously irradiated to > 50 Gy (delivered in =< 3 Gy/fraction)
- Whole lung previously irradiated with prior volume 20 Gy (V20Gy) > 30% (delivered
in =< 3 Gy/fraction)
- Primary tumor irradiated with SBRT
- Metastasis irradiated with SBRT
- Severe, active co-morbidity, defined as follows:
- Unstable angina and/or congestive heart failure requiring hospitalization within
the last 6 months prior to registration
- Transmural myocardial infarction within the last 6 months prior to registration
- Acute bacterial or fungal infection requiring intravenous antibiotics at the time
of registration
- Chronic obstructive pulmonary disease exacerbation or other respiratory illness
requiring hospitalization or precluding study therapy within 30 days prior to
registration
- Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic
disease
- Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)
4 count < 200 cells/microliter; note that patients who are HIV positive are
eligible, provided they are under treatment with highly active antiretroviral
therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior
to registration; note also that HIV testing is not required for eligibility for
this protocol
- End-stage renal disease (i.e., on dialysis or dialysis has been recommended)
- Pregnancy or women of childbearing potential not willing/able to use medically
acceptable forms of contraception during protocol treatment or for at least 6 months
following treatment
We found this trial at
75
sites
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2011
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
Click here to add this to my saved trials
1201 Camino de Salud Northeast
Albuquerque, New Mexico 87131
Albuquerque, New Mexico 87131
(505) 272-4946
Principal Investigator: Gregory N. Gan
Phone: 505-925-0366
University of New Mexico Cancer Center It’s been 40 years since the New Mexico State...
Click here to add this to my saved trials
1500 E Duarte Rd
Duarte, California 91010
Duarte, California 91010
(626) 256-4673
Principal Investigator: Savita V. Dandapani
Phone: 800-826-4673
City of Hope Comprehensive Cancer Center City of Hope is a leading research and treatment...
Click here to add this to my saved trials
655 West 8th Street
Jacksonville, Florida 32209
Jacksonville, Florida 32209
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Yuhchyau Chen
Phone: 585-341-8113
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
Anderson, Indiana 46016
Principal Investigator: Alexander M. Yeh
Phone: 765-646-8358
Click here to add this to my saved trials
1500 East Medical Center Drive
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
800-865-1125
Principal Investigator: Daniel E. Spratt
Phone: 734-763-7370
University of Michigan Comprehensive Cancer Center The U-M Comprehensive Cancer Center's mission is the conquest...
Click here to add this to my saved trials
Arlington Heights, Illinois 60005
Principal Investigator: Stephen S. Nigh
Phone: 847-618-4968
Click here to add this to my saved trials
Atlanta, Georgia 30303
Principal Investigator: Pretesh R. Patel
Phone: 404-778-1868
Click here to add this to my saved trials
550 Peachtree St NE
Atlanta, Georgia 30308
Atlanta, Georgia 30308
(404) 686-4411
Principal Investigator: Pretesh R. Patel
Phone: 404-778-1868
Emory University Hospital Midtown Emory University Hospital Midtown is a 511-bed community-based, acute care teaching...
Click here to add this to my saved trials
Atlanta, Georgia 30322
Principal Investigator: Pretesh R. Patel
Phone: 404-778-1868
Click here to add this to my saved trials
12605 East 16th Avenue
Aurora, Colorado 80045
Aurora, Colorado 80045
720-848-0000
Principal Investigator: Rachel A. Rabinovitch
Phone: 720-848-0650
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
Click here to add this to my saved trials
22 South Greene Street
Baltimore, Maryland 21201
Baltimore, Maryland 21201
410-328-7904
Principal Investigator: Steven J. Feigenberg
Phone: 800-888-8823
University of Maryland Greenebaum Cancer Center The University of Maryland Marlene and Stewart Greenebaum Cancer...
Click here to add this to my saved trials
Bel Air, Maryland 21014
Principal Investigator: Navesh K. Sharma
Phone: 800-888-8823
Click here to add this to my saved trials
8901 Rockville Pike
Bethesda, Maryland 20889
Bethesda, Maryland 20889
(301) 295-4000
Walter Reed National Military Medical Center The Walter Reed National Military Medical Center is one...
Click here to add this to my saved trials
Birmingham, Alabama 35233
Principal Investigator: Jennifer F. De Los Santos
Phone: 800-828-8816
Click here to add this to my saved trials
Boston, Massachusetts 02118
Principal Investigator: Lisa A. Kachnic
Phone: 800-811-8480
Click here to add this to my saved trials
Bronx, New York 10467
Principal Investigator: Nitin Ohri
Phone: 718-904-2730
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: David T. Marshall
Phone: 843-792-9321
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
Chicago, Illinois 60611
Principal Investigator: John P. Hayes
Phone: 312-695-1301
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
Chicago, Illinois 60637
1-773-702-6180
Principal Investigator: Steven J. Chmura
Phone: 312-355-3046
University of Chicago Comprehensive Cancer Center The University of Chicago Comprehensive Cancer Center (UCCCC) is...
Click here to add this to my saved trials
Cincinnati, Ohio 45219
Principal Investigator: Kevin P. Redmond
Phone: 513-558-4553
Click here to add this to my saved trials
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
Cleveland, Ohio 44106
(216) 444-2200
Principal Investigator: Samuel T. Chao
Phone: 866-223-8100
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Jose G. Bazan
Phone: 800-293-5066
Click here to add this to my saved trials
4050 Coon Rapids Blvd NW
Coon Rapids, Minnesota 55433
Coon Rapids, Minnesota 55433
(763) 236-6000
Principal Investigator: Paul W. Sperduto
Phone: 952-993-1517
Mercy Hospital Mercy Hospital, located in Coon Rapids, Minnesota, is a 271-bed non-profit hospital that...
Click here to add this to my saved trials
2300 N Edward St
Decatur, Illinois 62526
Decatur, Illinois 62526
(217) 876-8121
Principal Investigator: James L. Wade
Phone: 309-243-3605
Decatur Memorial Hospital An American flag bearing only 48 stars waved above Decatur Memorial Hospital...
Click here to add this to my saved trials
1200 Pleasant St
Des Moines, Iowa 50309
Des Moines, Iowa 50309
(515) 241-6212
Principal Investigator: Robert J. Behrens
Phone: 515-239-2621
Iowa Methodist Medical Center Iowa Methodist Medical Center was established in 1901 in a single...
Click here to add this to my saved trials
2799 W Grand Blvd
Detroit, Michigan 48202
Detroit, Michigan 48202
(313) 916-2600
Principal Investigator: Eleanor M. Walker
Phone: 313-916-1784
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
Click here to add this to my saved trials
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Joseph K. Salama
Phone: 773-834-7424
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Flint, Michigan 48532
Principal Investigator: Kiran Devisetty
Phone: 989-667-6257
Click here to add this to my saved trials
1024 S Lemay Ave
Fort Collins, Colorado 80524
Fort Collins, Colorado 80524
(970) 495-7000
Principal Investigator: Rachel A. Rabinovitch
Phone: 720-848-0650
Poudre Valley Hospital A 270-bed regional medical center offering a wide array of treatments, surgeries,...
Click here to add this to my saved trials
2200 Randallia Drive
Fort Wayne, Indiana 46805
Fort Wayne, Indiana 46805
Principal Investigator: Brian K. Chang
Phone: 260-373-8888
Click here to add this to my saved trials
1600 Southwest Archer Road
Gainesville, Florida 32610
Gainesville, Florida 32610
Click here to add this to my saved trials
Greenwood, South Carolina 29646
Principal Investigator: David T. Marshall
Phone: 843-792-9321
Click here to add this to my saved trials
Indianapolis, Indiana 46202
Principal Investigator: Gordon A. Watson
Phone: 800-248-1199
Click here to add this to my saved trials
Iowa City, Iowa 52242
Principal Investigator: Mark C. Smith
Phone: 800-237-1225
Click here to add this to my saved trials
La Crosse, Wisconsin
Principal Investigator: Collin D. Driscoll
Phone: 608-775-2385
Click here to add this to my saved trials
3855 Health Sciences Dr,
La Jolla, California 92093
La Jolla, California 92093
(858) 822-6100
Principal Investigator: James J. Urbanic
Phone: 858-822-5354
UC San Diego Moores Cancer Center Established in 1978, UC San Diego Moores Cancer Center...
Click here to add this to my saved trials
Click here to add this to my saved trials
Lexington, Kentucky
Principal Investigator: Ronald C. McGarry
Phone: 859-257-3379
Click here to add this to my saved trials
1441 Eastlake Ave
Los Angeles, California 90033
Los Angeles, California 90033
(323) 865-3000
Principal Investigator: Naomi R. Schechter
Phone: 323-865-0451
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
Click here to add this to my saved trials
Louisville, Kentucky 40202
Principal Investigator: Neal E. Dunlap
Phone: 866-530-5516
Click here to add this to my saved trials
2160 South 1st Avenue
Maywood, Illinois 60153
Maywood, Illinois 60153
(888) 584-7888
Principal Investigator: Abhishek A. Solanki
Phone: 708-202-8387
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
Click here to add this to my saved trials
Miami, Florida 33136
Principal Investigator: Lorraine Portelance
Phone: 305-243-2647
Click here to add this to my saved trials
9200 W Wisconsin Ave
Milwaukee, Wisconsin 53226
Milwaukee, Wisconsin 53226
(414) 805-3666
Principal Investigator: Elizabeth M. Gore
Phone: 414-805-4380
Froedtert and the Medical College of Wisconsin Froedtert Health combines with the Medical College of...
Click here to add this to my saved trials
Milwaukee, Wisconsin 53295
Principal Investigator: Elizabeth M. Gore
Phone: 888-469-6614
Click here to add this to my saved trials
Click here to add this to my saved trials
Mount Holly, New Jersey 08060
Principal Investigator: Lemuel S. Ariaratnam
Phone: 609-914-6762
Click here to add this to my saved trials
Mount Laurel, New Jersey 08054
Principal Investigator: Benjamin Goldsmith
Phone: 856-325-6757
Click here to add this to my saved trials
5475 South 500 East
Ogden, Utah 84405
Ogden, Utah 84405
Principal Investigator: Brandon J. Fisher
Phone: 412-339-5294
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
Omaha, Nebraska 68198
(402) 559-4000
Principal Investigator: Andrew O. Wahl
Phone: 402-559-6941
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Peoria, Illinois 61637
Principal Investigator: James L. Wade
Phone: 309-243-3605
Click here to add this to my saved trials
Click here to add this to my saved trials
Pontiac, Michigan 48341
Principal Investigator: Samir Narayan
Phone: 208-367-7954
Click here to add this to my saved trials
1015 NW 22nd Ave
Portland, Oregon 97210
Portland, Oregon 97210
(503) 413-7711
Legacy Good Samaritan Hospital and Medical Center Located in the heart of Northwest Portland, Legacy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Sacramento, California 95817
Principal Investigator: Megan E. Daly
Phone: 916-734-3089
Click here to add this to my saved trials
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Clifford G. Robinson
Phone: 800-600-3606
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Click here to add this to my saved trials
2000 Circle of Hope Dr
Salt Lake City, Utah 84112
Salt Lake City, Utah 84112
(801) 585-0303
Huntsman Cancer Institute at University of Utah Huntsman Cancer Institute (HCI) is part of the...
Click here to add this to my saved trials
701 N 1st St
Springfield, Illinois 62781
Springfield, Illinois 62781
(217) 788-3000
Principal Investigator: James L. Wade
Phone: 309-243-3605
Memorial Medical Center Memorial Medical Center is a Magnet-designated, acute care hospital in Springfield that...
Click here to add this to my saved trials
Click here to add this to my saved trials
Toms River, New Jersey 08755
Principal Investigator: David J. D'Ambrosio
Phone: 732-818-3882
Click here to add this to my saved trials
Click here to add this to my saved trials
Tucson, Arizona 85724
Principal Investigator: Baldassarre Stea
Phone: 520-626-9008
Click here to add this to my saved trials
Voorhees, New Jersey 08043
Principal Investigator: Lemuel S. Ariaratnam
Phone: 609-914-6762
Click here to add this to my saved trials
West Bloomfield, Michigan 48322
Principal Investigator: Eleanor M. Walker
Phone: 313-916-1784
Click here to add this to my saved trials
Click here to add this to my saved trials
300 South 6th Avenue
West Reading, Pennsylvania 19611
West Reading, Pennsylvania 19611
(610) 988-8000
Principal Investigator: Terrence P. Cescon
Phone: 610-988-9323
Reading Hospital At Reading Health System, advancing your health and wellness is our mission. When...
Click here to add this to my saved trials
929 N St Francis St
Wichita, Kansas 67214
Wichita, Kansas 67214
(316) 268-5775
Principal Investigator: Shaker R. Dakhil
Phone: 316-268-5374
Via Christi Regional Medical Center Via Christi Health's rich history of serving the people of...
Click here to add this to my saved trials